Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 336
Filter
1.
Bone Joint J ; 104-B(2): 227-234, 2022 Feb.
Article in English | MEDLINE | ID: mdl-35094571

ABSTRACT

AIMS: Septic arthritis of the hip often leads to irreversible osteoarthritis (OA) and the requirement for total hip arthroplasty (THA). The aim of this study was to report the mid-term risk of any infection, periprosthetic joint infection (PJI), aseptic revision, and reoperation in patients with a past history of septic arthritis who underwent THA, compared with a control group of patients who underwent THA for OA. METHODS: We retrospectively identified 256 THAs in 244 patients following septic arthritis of the native hip, which were undertaken between 1969 and 2016 at a single institution. Each case was matched 1:1, based on age, sex, BMI, and year of surgery, to a primary THA performed for OA. The mean age and BMI were 58 years (35 to 84) and 31 kg/m2 (18 to 48), respectively, and 100 (39%) were female. The mean follow-up was 11 years (2 to 39). RESULTS: The ten-year survival free of any infection was 91% and 99% in the septic arthritis and OA groups, respectively (hazard ratio (HR) = 13; p < 0.001). The survival free of PJI at ten years was 93% and 99% in the septic arthritis and OA groups, respectively (HR = 10; p = 0.002). There was a significantly higher rate of any infection at ten years when THA was undertaken within five years of the diagnosis of septic arthritis compared with those in whom THA was undertaken > five years after this diagnosis was made (14% vs 5%, respectively; HR = 3.1; p = 0.009), but there was no significant difference in ten-year survival free of aseptic revision (HR = 1.14; p = 0.485). The mean Harris Hip Scores at two and five years postoperatively were significantly lower in the septic arthritis group compared with the OA group (p = 0.001 for both). CONCLUSION: There was a ten-fold increased risk of PJI in patients with a history of septic arthritis who underwent THA compared with those who underwent THA for OA with a ten-year cumulative incidence of 7%. The risk of any infection had a strong downward trend as the time interval between the diagnosis of septic arthritis and THA increased, highlighted by a 3.1-fold higher risk when THAs were performed within five years of the diagnosis being made. Cite this article: Bone Joint J 2022;104-B(2):227-234.


Subject(s)
Arthritis, Infectious/surgery , Arthroplasty, Replacement, Hip , Bacterial Infections/surgery , Candidiasis/surgery , Cryptococcosis/surgery , Hip Joint , Osteoarthritis, Hip/surgery , Adult , Aged , Aged, 80 and over , Case-Control Studies , Disease-Free Survival , Female , Follow-Up Studies , Hip Joint/microbiology , Hip Joint/surgery , Hip Prosthesis/adverse effects , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Proportional Hazards Models , Prosthesis-Related Infections/epidemiology , Prosthesis-Related Infections/etiology , Reoperation/statistics & numerical data , Retrospective Studies , Treatment Outcome
2.
Bone Joint J ; 104-B(2): 212-220, 2022 Feb.
Article in English | MEDLINE | ID: mdl-35094572

ABSTRACT

AIMS: Femoral cement-in-cement revision is a well described technique to reduce morbidity and complications in hip revision surgery. Traditional techniques for septic revision of hip arthroplasty necessitate removal of all bone cement from the femur. In our two centres, we have been using a cement-in-cement technique, leaving the distal femoral bone cement in selected patients for septic hip revision surgery, both for single and the first of two-stage revision procedures. A prerequisite for adoption of this technique is that the surgeon considers the cement mantle to be intimately fixed to bone without an intervening membrane between cement and host bone. We aim to report our experience for this technique. METHODS: We have analyzed patients undergoing this cement-in-cement technique for femoral revision in infection, and present a consecutive series of 89 patients. Follow-up was undertaken at a mean of 56.5 months (24.0 to 134.7) for the surviving cases. RESULTS: Seven patients (7.9%) required further revision for infection. Ten patients died of causes unrelated to their infection before their two-year review (mean 5.9 months; 0.9 to 18.6). One patient was lost to follow-up at five months after surgery, and two patients died of causes unrelated to their hip shortly after their two-year review was due without attending. Of the remaining patients, 69 remained infection-free at final review. Radiological review confirms the mechanical success of the procedure as previously described in aseptic revision, and postoperative Oxford Hip Scores suggest satisfactory functional outcomes. CONCLUSION: In conclusion, we found that retaining a well-fixed femoral cement mantle in the presence of infection and undertaking a cement-in-cement revision was successful in 82 of the patients (92.1%) in our series of 89, both in terms of eradication of infection and component fixation. These results are comparable to other more invasive techniques and offer significant potential benefits to the patient. Cite this article: Bone Joint J 2022;104-B(2):212-220.


Subject(s)
Arthroplasty, Replacement, Hip/methods , Bacterial Infections/surgery , Bone Cements , Candidiasis/surgery , Hip Prosthesis , Prosthesis-Related Infections/surgery , Reoperation/methods , Adult , Aged , Aged, 80 and over , Arthroplasty, Replacement, Hip/instrumentation , Bacterial Infections/etiology , Candidiasis/etiology , Female , Follow-Up Studies , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Reoperation/instrumentation , Treatment Outcome
3.
Clin Neurol Neurosurg ; 212: 107058, 2022 01.
Article in English | MEDLINE | ID: mdl-34844162

ABSTRACT

A 28-year-old woman with anorexia nervosa (AN) and Candida brain abscesses was transferred to our hospital for intensive treatment. On admission, she had a low-grade fever but no clinical neurological abnormalities were observed, even though she had a high-grade fever in the previous hospital. These clinical findings did not suggest a serious disorder in the brain. However, magnetic resonance imaging showed mass lesions in bilateral lentiform nuclei in addition to several abscesses in the whole body. The fungal cultures of specimens from abscesses on the anterior chest wall and iliopsoas muscle detected Candida albicans. She was treated with antifungal therapy (fosfluconazole, fluconazole, liposomal amphotericin B, and flucytosine) and two emergent craniotomies for drainage of the intracranial fluid. Thereafter, antifungal medications (voriconazole and flucytosine) were administered for six months as a longterm treatment, which abolished most abscesses. However, severe frontal lobe dysfunction persisted as a residual symptom. This case suggests that AN can mask clinical manifestations of infection. We should always consider the possibility of infectious complications in these patients.


Subject(s)
Anorexia Nervosa/therapy , Brain Abscess/diagnosis , Candida albicans/pathogenicity , Candidiasis/diagnosis , Parenteral Nutrition, Total , Adult , Brain Abscess/drug therapy , Brain Abscess/surgery , Candidiasis/drug therapy , Candidiasis/surgery , Female , Humans
4.
BMC Infect Dis ; 21(1): 416, 2021 May 04.
Article in English | MEDLINE | ID: mdl-33947342

ABSTRACT

BACKGROUND: Prosthetic joint infection (PJI) is one of the most feared complications following total arthroplasty surgeries. Gram-positive bacteria are the most common microorganisms implicated in PJIs, while infections mediated by fungi only account for 1% of cases. When dealing with PJIs, a two-stage revision arthroplasty is widely used. Briefly, a spacer is introduced until re-implantation of the definitive prosthesis to provide skeleton stabilization while delivering antibiotics in the site of the infection. Sometimes, antimicrobial therapy may fail, but the isolation of a second microorganism from the spacer is uncommon and even less frequent that of a yeast. CASE PRESENTATION: Here is described a case of a 75-year-old woman who underwent two-stage revision surgery of the left hip prosthesis secondary to a Staphylococcus capitis infection, whose spacer was found to be infected by Candida albicans at a later time. Briefly, the patient underwent revision surgery of the hip prosthesis for a suspected PJI. After the debridement of the infected tissue, an antibiotic-loaded spacer was implanted. The microbiological analysis of the periprosthetic tissues and the implant depicted a S. capitis infection that was treated according to the antimicrobial susceptibility profile of the clinical isolate. Three months later, the patient was admitted to the emergency room due to local inflammatory signs. Synovial fluid was sent to the laboratory for culture. No evidence of S. capitis was detected, however, a yeast was identified as Candida albicans. Fifteen days later, the patient was hospitalized for the removal of the infected spacer. Microbiological cultures confirmed the results of the synovial fluid analysis. According to the susceptibility profile, the patient was treated with fluconazole (400 mg/day) for 6 months. Seven months later, the patient underwent second-stage surgery. The microbiological tests on the spacer were all negative. After 12 months of follow-up, the patient has fully recovered and no radiological signs of infection have been detected. CONCLUSIONS: Given the exceptionality of this complication, it is important to report these events to better understand the clinical outcomes after the selected therapeutic options to prevent and forestall the development of either bacterial or fungal spacer infections.


Subject(s)
Candidiasis/surgery , Hip Prosthesis/adverse effects , Prosthesis-Related Infections/microbiology , Prosthesis-Related Infections/surgery , Staphylococcal Infections/surgery , Aged , Anti-Bacterial Agents/therapeutic use , Arthroplasty, Replacement, Hip , Candida albicans/isolation & purification , Candidiasis/microbiology , Female , Humans , Reoperation , Staphylococcal Infections/microbiology , Staphylococcus capitis/pathogenicity
5.
Neurochirurgie ; 67(2): 157-164, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33450269

ABSTRACT

Fungal spondylodiscitis is rare (0.5%-1.6% of spondylodiscitis) and mainly caused by Candida albicans. Surgical intervention in spondylodiscitis patients is indicated for compression of neural elements, spinal instability, severe kyphosis, failure of conservative management and intractable pain. However, there is no evidence-based optimal surgical approach for spondylodiscitis. There have been only case reports of surgical treatment for Candida spondylodiscitis. We evaluated the preliminary results of the efficacy and safety of one-stage debridement via oblique lateral corridor with interbody fusion (OLIF) using stand-alone cement reconstruction after debridement for the treatment of Candida spondylodiscitis in patients with major co-morbidities. Five patients (4 males, 1 female, mean age: 64.2 years) suffering from Candida albicans lumbar spondylodiscitis who underwent this procedure were studied. Their predominant symptoms were unremitting back and leg pain and all had pre and postoperative anti-fungal therapy under microbiologist supervision. The operative time ranged from 137minutes to 260minutes (mean: 213.4minutes). The mean blood loss was 160mL (range: 100-200mL). There were no perioperative complications. At follow-up all showed major improvement in pain and ambulatory status. CT scan showed radiological stability for all patients at 6-12 months. Our preliminary results showed stand-alone anterior debridement and spinal re-construction with cement through mini-open OLIF approach might be a safe and effective option for patients with spinal fungal infection and major comorbidities.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Bone Cements/therapeutic use , Candidiasis/surgery , Debridement/methods , Discitis/surgery , Lumbar Vertebrae/surgery , Aged , Candida albicans/isolation & purification , Candidiasis/diagnostic imaging , Comorbidity , Debridement/trends , Discitis/diagnostic imaging , Female , Follow-Up Studies , Humans , Lumbar Vertebrae/diagnostic imaging , Male , Middle Aged , Retrospective Studies , Treatment Outcome
6.
Rom J Intern Med ; 59(1): 93-98, 2021 Mar 01.
Article in English | MEDLINE | ID: mdl-33170145

ABSTRACT

Liver abscesses are rare entities for which percutaneous drainage is traditionally employed. The technique is simple, but associated with a significant rate of side effects and patient discomfort. We herein report a case of fungal left liver lobe abscess that was successfully treated by using EUS-guided drainage, with insertion of a large caliber lumen-apposing metal stent. The literature review we performed on the topic seems to favor, at least for abscess in the left and/or caudate liver lobes, EUS as compared to percutaneous drainage.


Subject(s)
Candidiasis/surgery , Drainage/methods , Liver Abscess/microbiology , Liver Abscess/surgery , Stents , Ultrasonography, Interventional/methods , Aged, 80 and over , Candida albicans , Female , Humans
7.
BMC Cardiovasc Disord ; 20(1): 469, 2020 10 31.
Article in English | MEDLINE | ID: mdl-33129270

ABSTRACT

BACKGROUND: Candida prosthetic endocarditis is associated with high mortality rates and valve replacement surgery, together with antifungal treatment, play a major role in eradicating the fungal infection. Valve reoperations in these scenarios may be relatively common due to the high infection relapse rates and, in some cases, heart transplantation may be an imposing therapy for infection resolution and for the heart failure related to the myocardial reoperation injury. Among the many postoperative complications related to heart transplantation, chylopericardium is a rare but challenging example. CASE PRESENTATION: We report the case of a 55-year-old man who was admitted to our hospital with a 1-month history of progressive dyspnea and fatigue. His past medical history included four open-heart surgeries for aortic and mitral valve replacement due to recurrent Candida parapsilosis infective endocarditis. Transthoracic echocardiogram showed a markedly reduced left ventricular systolic function and normofunctioning bioprosthetic valves. An inotropic dependency condition led to heart transplantation surgery. In the early postoperative period, a persistent chylous fluid started to drain from the pericardial tube, compatible with the diagnosis of chylopericardium. The lack of clinical response to total parenteral nutrition and intravenous infusion of octreotide imposed the need of interventional radiology with diagnostic lymphography through cisterna chyli puncture and thoracic duct catheterization, confirming the presence of a lymphatic fistula. A successful treatment outcome was achieved with percutaneous thoracic duct embolization using coils and n-butyl-cyanoacrilate glue, possibiliting hospital discharge. CONCLUSIONS: Fungal endocarditis requires combined treatment (surgical and antimicrobial) for eradication. Valve replacement, while necessary, may lead to severe ventricular deterioration and heart transplantation may be the only viable therapeutic solution. Among the several postoperative complications of heart transplantation, chylopericardium is an uncommon and defiant example. Advances in interventional radiology like the percutaneous embolization allow a less invasive and highly efficient approach for this complication.


Subject(s)
Candida parapsilosis/pathogenicity , Candidiasis/surgery , Endocarditis/surgery , Fistula/etiology , Heart Transplantation/adverse effects , Heart Valve Prosthesis Implantation , Lymphatic Diseases/etiology , Pericardial Effusion/etiology , Antifungal Agents/therapeutic use , Candidiasis/diagnosis , Candidiasis/microbiology , Embolization, Therapeutic , Endocarditis/diagnosis , Endocarditis/microbiology , Fistula/diagnostic imaging , Fistula/therapy , Humans , Lymphatic Diseases/diagnostic imaging , Lymphatic Diseases/therapy , Male , Middle Aged , Pericardial Effusion/diagnostic imaging , Pericardial Effusion/therapy , Recurrence , Treatment Outcome
8.
BMC Infect Dis ; 20(1): 739, 2020 Oct 08.
Article in English | MEDLINE | ID: mdl-33032533

ABSTRACT

BACKGROUND: Invasive infections with Candida krusei are uncommon and rarely complicated by spondylitis. Previous described cases were solely treated with antimycotic therapy, despite guidelines recommending surgical interventions. CASE PRESENTATION: We describe a case of C. krusei spondylitis in a patient treated with chemotherapy for acute myeloid leukemia. After induction chemotherapy, the patient developed a candidemia, which was treated with micafungin. One month after the candidemia, the patient was admitted with severe lumbar pain. Spondylitis of the L4 and L5 vertebra was diagnosed on MR-imaging, with signs suggesting an atypical infection. The patient was treated with anidulafungin combined with voriconazole. Despite maximal conservative management symptoms gradually worsened eventually requiring surgical intervention. CONCLUSIONS: In contrast to previous case reports, antimycotic treatment alone could be insufficient in treating C. krusei spondylitis.


Subject(s)
Candida/drug effects , Candidiasis/immunology , Immunocompromised Host , Spondylitis/drug therapy , Spondylitis/immunology , Aged , Anidulafungin/therapeutic use , Antifungal Agents/therapeutic use , Candidemia/chemically induced , Candidemia/drug therapy , Candidiasis/drug therapy , Candidiasis/microbiology , Candidiasis/surgery , Humans , Induction Chemotherapy/adverse effects , Male , Micafungin/therapeutic use , Spondylitis/microbiology , Spondylitis/surgery , Treatment Outcome , Voriconazole/therapeutic use
9.
J Mycol Med ; 30(4): 101024, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32826154

ABSTRACT

Candida species are the commensal organisms of human mucosa and opportunistically cause the diseases in susceptible persons. This study aimed to determine the prevalence and virulence of different Candida spp. among nephrolithiatic patients and their association with complicated UTI (cUTI). A total of 164 urine samples were collected from surgical units of two tertiary care hospitals (Poly Clinic and Pakistan Institute of Medical Sciences Hospital, Islamabad). From 74 kidney stone patients, 77 isolates of Candida spp. were confirmed through standard microbiological and molecular characterization. C. albicans was the predominant species with 51 isolates (66.2%) followed by 26 (33.8%) of C. non-albicans. The nephrolithiatic patients suffering from cUTI were more prone to be infected with Candida (P=0.047). Among all isolates, 83% (64) of the Candida isolates were biofilm formers, 80% (60) showed the esterase production and 64.9% (50) showed phospholipase production. Candida isolates positive for various virulence factors were more prevalently isolated from both catheterized and recurrent UTI patients. Among Candida spp., 16.9% (13) isolates showed resistance to fluconazole and 19.5% (15) against voriconazole and 11 isolates were resistant for both tested antifungals. Candida isolated from cUTI cases showed comparatively enhanced virulence attributes and antifungal resistance, suggesting that these factors might have role in development of cUTI in nephrolithiatic patients. Hence, this work highlights the high prevalence of both C. albicans and non albicans spp. in nephrolithiatic patients. So, there is need to administer evidence based antifungal therapy rather than empirical therapy to reduce the cUTI in nephrolithiatic patients.


Subject(s)
Candida/isolation & purification , Nephrolithiasis/epidemiology , Nephrolithiasis/microbiology , Urinary Tract Infections/epidemiology , Urinary Tract Infections/microbiology , Adult , Aged , Aged, 80 and over , Antifungal Agents/pharmacology , Candida/classification , Candida/drug effects , Candidiasis/complications , Candidiasis/epidemiology , Candidiasis/microbiology , Candidiasis/surgery , Drug Resistance, Fungal/drug effects , Female , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Nephrolithiasis/complications , Nephrolithiasis/surgery , Pakistan/epidemiology , Prevalence , Surgery Department, Hospital/statistics & numerical data , Tertiary Care Centers/statistics & numerical data , Urinary Tract Infections/complications , Urinary Tract Infections/surgery
10.
Arch. Soc. Esp. Oftalmol ; 95(1): 34-37, ene. 2020. ilus
Article in Spanish | IBECS | ID: ibc-195315

ABSTRACT

Mujer de 62 años con disminución de la agudeza visual bilateral rápidamente progresiva y panuveítis con celulitis orbitaria, asociadas a mal estado general, emesis y fiebre. Se diagnosticó septicemia por Klebsiella pneumoniae y panoftalmitis endógena bilateral. La afectación ocular progresó rápidamente a escleroqueratitis y perforación en ambos ojos, pese a recibir manejo antibiótico sistémico de amplio espectro. Finalmente, la paciente requirió enucleación bilateral. Los cultivos microbiológicos de las piezas quirúrgicas identificaron Klebsiella pneumoniae y Candida magnoliae. Según nuestro conocimiento, es el tercer caso publicado que haya requerido enucleación o evisceración bilateral por panoftalmitis endógena y el primer caso de infección ocular endógena causada por Candida magnoliae


The case is presented of a 62 year-old woman with a rapid, progressive bilateral decrease in visual acuity and panuveitis with orbital cellulitis. She was also in poor general condition, with emesis and fever. Septicaemia due to Klebsiella pneumoniae and bilateral endogenous panophthalmitis were diagnosed. The ocular infection quickly progressed to sclerokeratitis and bilateral perforation despite broad spectrum systemic antibiotic management, and eventually the patient required bilateral enucleation. Microbiological cultures of the surgical pieces identified Klebsiella pneumoniae and Candida magnoliae. To our knowledge, this is the third published case that required bilateral enucleation or evisceration due to endogenous panophthalmitis, and the first case of endogenous ocular infection caused by Candida magnoliae


Subject(s)
Humans , Female , Middle Aged , Candidiasis/surgery , Eye Enucleation , Klebsiella Infections/surgery , Klebsiella pneumoniae/isolation & purification , Panophthalmitis/surgery , Anti-Bacterial Agents/therapeutic use , Candidiasis/microbiology , Coinfection/surgery , Combined Modality Therapy , Corneal Perforation/etiology , Disease Progression , Klebsiella Infections/microbiology , Orbital Cellulitis/drug therapy , Orbital Cellulitis/surgery , Panophthalmitis/drug therapy
11.
Int Orthop ; 44(1): 15-22, 2020 01.
Article in English | MEDLINE | ID: mdl-31254016

ABSTRACT

PURPOSE: To produce a systematic analysis of types of treatment and outcomes of Candida hip periprosthetic joint infections and their correlation with specific pathogen species. METHODS: During June 2018, a literature search of candida periprosthetic hip infection in PubMed, Scopus and Embase databases was performed according to the PRISMA (Preferred Reporting Item for Systematic Reviews and Meta-Analyses) guideline. Reviewers used Oxford level of evidence (LoE) and methodological index for non-randomised studies (MINORS) score. Modal distribution of surgical, pharmacological treatment and outcome along with the correlation between types of treatment and outcomes was calculated through the chi-square test. RESULTS: Seventy-nine cases were collected through 35 articles, identifying 81 pathogens. Candida albicans was the most common pathogen. Analysis of LoE reveals 26 LoE 5 (74.29%) and nine LoE 4 (26.71%). From nine  LoE 4, ten patients (20.41%) underwent one-stage revision, 22 patients (44.90%) two-stage revision, 11 patients (22.45%) resection arthroplasty and six patients (12.24%) debridement with prosthesis retention. Global success was obtained in 31 cases (63.27%). Modal distribution revealed a preference for two-stage revision (22/49) and fluconazole as medical therapy (36/49). A significant difference was found between one-stage revision and resection arthroplasty (p = 0.031) or debridement (p = 0.003) and between two-stage revision and debridement (p = 0.013). No differences were found between Candida spp. in terms of the outcomes (p = 0.736). Methodological index showed a poor MINOR score. CONCLUSIONS: Analysis of the literature suggests better clinical outcome with one- or two-stage revision than with resection arthroplasty or debridement, but the level of evidence is low.


Subject(s)
Arthroplasty, Replacement, Hip/adverse effects , Candidiasis/surgery , Hip Joint/surgery , Prosthesis-Related Infections/surgery , Candidiasis/etiology , Debridement , Hip Joint/microbiology , Hip Prosthesis/microbiology , Humans , Prosthesis Retention , Prosthesis-Related Infections/etiology , Reoperation , Treatment Outcome
12.
Eur J Ophthalmol ; 30(1): 88-93, 2020 Jan.
Article in English | MEDLINE | ID: mdl-30474397

ABSTRACT

PURPOSE: To identify the causative microorganism of fungal endogenous endophthalmitis in our tertiary referral uveitis center and review the therapeutic role of pars plana vitrectomy in patients with fungal endogenous endophthalmitis. METHODS: Seven eyes of six cases were identified as fungal endogenous endophthalmitis through positive cultures of ocular fluids and clinical presentations. The final anatomical and functional results were evaluated. RESULTS: Four women (66.7%) and two men (33.3%) underwent vitrectomy. Control of infection was achieved early on in all cases. Candida (71.4%) and Aspergillus (28.6%) species were identified as causative fungi in patients with fungal endogenous endophthalmitis. Two patients were reoperated due to reinfection and retinal detachment, respectively. Visual acuity improved in six eyes (85.7%) and worsened in one eye (14.3%). At the final examination, the retina was flat in all cases. No eye developed phthisis bulbi. CONCLUSION: Candida species are the most common causative organisms of fungal endogenous endophthalmitis in this study. Pars plana vitrectomy in fungal endogenous endophthalmitis may enhance the treatment of infection by removing fungal elements in the vitreous and aid in diagnosis. Vitrectomy may also be an important tool in the management of vision-threatening post-infectious sequelae such as retinal detachment and reinfections.


Subject(s)
Aspergillosis/surgery , Candidiasis/surgery , Endophthalmitis/surgery , Eye Infections, Fungal/surgery , Vitrectomy/methods , Adult , Aged , Aspergillosis/microbiology , Aspergillosis/physiopathology , Candidiasis/microbiology , Candidiasis/physiopathology , Endophthalmitis/microbiology , Endophthalmitis/physiopathology , Eye Infections, Fungal/microbiology , Eye Infections, Fungal/physiopathology , Female , Humans , Male , Middle Aged , Reoperation , Retinal Detachment/surgery , Retrospective Studies , Tertiary Care Centers , Visual Acuity/physiology , Vitreous Body/microbiology , Young Adult
13.
Arch Soc Esp Oftalmol (Engl Ed) ; 95(1): 34-37, 2020 Jan.
Article in English, Spanish | MEDLINE | ID: mdl-31767407

ABSTRACT

The case is presented of a 62 year-old woman with a rapid, progressive bilateral decrease in visual acuity and panuveitis with orbital cellulitis. She was also in poor general condition, with emesis and fever. Septicaemia due to Klebsiella pneumoniae and bilateral endogenous panophthalmitis were diagnosed. The ocular infection quickly progressed to sclerokeratitis and bilateral perforation despite broad spectrum systemic antibiotic management, and eventually the patient required bilateral enucleation. Microbiological cultures of the surgical pieces identified Klebsiella pneumoniae and Candida magnoliae. To our knowledge, this is the third published case that required bilateral enucleation or evisceration due to endogenous panophthalmitis, and the first case of endogenous ocular infection caused by Candida magnoliae.


Subject(s)
Candidiasis/surgery , Eye Enucleation , Klebsiella Infections/surgery , Klebsiella pneumoniae/isolation & purification , Panophthalmitis/surgery , Anti-Bacterial Agents/therapeutic use , Candidiasis/microbiology , Coinfection/surgery , Combined Modality Therapy , Corneal Perforation/etiology , Disease Progression , Female , Humans , Klebsiella Infections/microbiology , Middle Aged , Orbital Cellulitis/drug therapy , Orbital Cellulitis/surgery , Panophthalmitis/drug therapy
14.
Infez Med ; 27(3): 328-331, 2019 Sep 01.
Article in English | MEDLINE | ID: mdl-31545778

ABSTRACT

Bloodstream infections caused by non-albicans Candida species are increasing and echinocandins have been extensively used especially in patients with hemodynamic instability, previous antifungal treatment and hospital risk factors for intrinsic or acquired resistance to azoles. Candida glabrata resistance to echinocandins is reported and is generally associated with previous use of echinocandins; FKS gene mutations have been associated with a worse outcome. We report the case of a 65-year-old woman who developed candidemia and endocarditis by C. glabrata with a newly acquired FKS mutation 24 months after successful treatment of infective endocarditis by C. glabrata with a double dosage of anidulafungin (200 mg daily) followed by oral voriconazole. Driven by high echinocandin MICs the strain taken by intraoperative cultures was further analyzed in a referral microbiology laboratory, confirming the new onset of point mutation S633P of the FKS2 gene.


Subject(s)
Anidulafungin/adverse effects , Antifungal Agents/adverse effects , Candida glabrata/genetics , Candidiasis/drug therapy , Endocarditis/drug therapy , Fungal Proteins/genetics , Point Mutation , Aged , Anidulafungin/therapeutic use , Antifungal Agents/therapeutic use , Candida glabrata/drug effects , Candidemia/drug therapy , Candidiasis/surgery , Endocarditis/microbiology , Endocarditis/surgery , Female , Fungal Proteins/drug effects , Heart Valve Prosthesis Implantation , Humans , Microbial Sensitivity Tests , Voriconazole/therapeutic use
16.
Kardiol Pol ; 77(7-8): 670-673, 2019 Aug 23.
Article in English | MEDLINE | ID: mdl-31215523

ABSTRACT

Fungal endocarditis (FE) is an infrequent but a lethal condition. Candida and Aspergillus species are the 2 most commonly implicated pathogenic fungi. Clinical presentation is most often that of a fever of unknown origin, which is hard to differentiate from bacterial endocarditis. The diagnosis of FE is extremely challenging and now shifting towards molecular diagnostic techniques. Rapid and aggressive treatment with a combination of antifungal therapy and surgical debridement is imperative to improve outcomes.


Subject(s)
Endocarditis/diagnosis , Mycoses/diagnosis , Aspergillosis/diagnosis , Aspergillosis/drug therapy , Aspergillosis/surgery , Candidiasis/diagnosis , Candidiasis/drug therapy , Candidiasis/surgery , Endocarditis/drug therapy , Endocarditis/surgery , Humans , Mycoses/drug therapy , Mycoses/surgery
17.
World Neurosurg ; 127: e202-e211, 2019 Jul.
Article in English | MEDLINE | ID: mdl-30878748

ABSTRACT

OBJECTIVE: To evaluate the efficacy and clinical results of full endoscopic debridement and drainage (FEDD) for high-risk patients with spondylodiscitis. METHODS: Fourteen patients who underwent FEDD at our institution between November 2015 and September 2017 were retrospectively reviewed. All patients had single-level infectious spondylodiscitis and were high-risk candidates for surgery. Their general condition was evaluated according to the American Society of Anesthesiologists grading system. The Charlson Comorbidity Index was used for comprehensive assessment of comorbidity status. Outcomes were evaluated by numeric rating scale (NRS) pain score, Oswestry Disability Index, modified Macnab criteria, and radiographic images at follow-up. RESULTS: All 14 patients experienced immediate relief of back pain after FEDD, with no procedure-related complications. The causative bacteria were identified in 10 of the 14 patients (71.5%). Half of the 14 patients had an American Society of Anesthesiologists score of ≥3. The average Charlson Comorbidity Index was 5.1 ± 1.6 points. Compared with the preoperative NRS score of 8.2 ± 0.9, the NRS scores at 1 week and 12 months after surgery were 3.4 ± 1.1 and 1.4 ± 1.2, respectively. A significant improvement in Oswestry Disability Index was observed after surgery (preoperative, 30.1 ± 3.9; 12 months postoperatively, 17.6 ± 6.2; P < 0.05). Satisfaction rate was 85.7% based on the Macnab criteria (excellent or good outcome). None of the patients developed any significant kyphotic deformity after FEDD. CONCLUSIONS: FEDD may be an effective alternative to extensive open surgery in patients with infectious spondylodiscitis, especially those who are high-risk candidates for surgery (elderly patients with multiple comorbidities and patients in poor general condition).


Subject(s)
Debridement/methods , Discitis/surgery , Diskectomy/methods , Drainage/methods , Lumbar Vertebrae/surgery , Neuroendoscopy/methods , Aged , Aged, 80 and over , Anti-Infective Agents/therapeutic use , Bacterial Infections/drug therapy , Bacterial Infections/surgery , Candidiasis/drug therapy , Candidiasis/surgery , Combined Modality Therapy , Comorbidity , Disability Evaluation , Discitis/complications , Discitis/drug therapy , Discitis/microbiology , Female , Fluoroscopy , Humans , Low Back Pain/etiology , Low Back Pain/surgery , Male , Middle Aged , Pain Measurement , Radiography, Interventional , Retrospective Studies
18.
J Bronchology Interv Pulmonol ; 26(2): 132-136, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30908392

ABSTRACT

Chronic pleural infection is characterized by thickened pleura and nonexpandable lung often requiring definitive surgical intervention, such as decortication and/or pleural obliteration procedures. Such procedures are associated with significant morbidity and require proper patient selection for a successful outcome. We report a cohort of 11 patients with pleural space infection and a nonexpandable lung treated with tunneled pleural catheters (TPCs). Following placement, hospital discharge and TPC removal occurred after a median of 5 and 36 days, respectively. Three patients presented with residual loculated effusion that resolved with instillation of intrapleural fibrinolytic therapy. One patient eventually required open window thoracostomy for ongoing pleural infection due to poor medical compliance with TPC care and drainage instructions. TPCs represent an alternative option for drainage of an infected pleural space in nonsurgical candidates with a nonexpandable lung. Their use, as a compliment to traditional treatment, may facilitate prompt hospital discharge and ambulatory management in patients with limited life expectancy.


Subject(s)
Catheters , Infections/surgery , Pleurisy/surgery , Thoracostomy , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Candidiasis/drug therapy , Candidiasis/surgery , Chest Tubes , Drainage , Escherichia coli Infections/drug therapy , Escherichia coli Infections/surgery , Female , Fluoroscopy , Fusobacterium Infections/drug therapy , Fusobacterium Infections/surgery , Humans , Infections/drug therapy , Male , Middle Aged , Pleurisy/drug therapy , Retrospective Studies , Staphylococcal Infections/drug therapy , Staphylococcal Infections/surgery , Streptococcal Infections/drug therapy , Streptococcal Infections/surgery , Thoracic Surgery, Video-Assisted , Thoracoscopy
19.
J Cardiothorac Surg ; 14(1): 41, 2019 Feb 26.
Article in English | MEDLINE | ID: mdl-30808391

ABSTRACT

BACKGROUND: Only 4.1% of tricuspid valve IE cases require surgical intervention. The complication after tricuspid valve IE with lung abscess and empyema is rare. CASE PRESENTATION: We report the case of a 38-year-old male (an intravenous drug abuser) diagnosed with tricuspid valve IE who underwent tricuspid valve replacement. The case was complicated by multiple lung abscesses and thoracic empyema. The pathogens causing the lung abscesses and empyema were Acinetobacter baumannii complex and Candida albicans, which were different from those causing the endocarditis. After 4 weeks of antibiotic treatment, chest X-ray revealed bilateral clear lung markings with only mild blunting of the right costophrenic angle. CONCLUSION: The pathogen causing the lung abscess is not always compatible with that causing the endocarditis. Thoracoscopic incision of the abscess with 4 to 6 weeks of broad-spectrum antibiotic treatment is effective and safe.


Subject(s)
Empyema, Pleural/microbiology , Endocarditis, Bacterial/microbiology , Lung Abscess/microbiology , Substance Abuse, Intravenous/microbiology , Tricuspid Valve/surgery , Acinetobacter Infections/drug therapy , Acinetobacter Infections/microbiology , Acinetobacter Infections/surgery , Acinetobacter baumannii/isolation & purification , Adult , Anti-Bacterial Agents/therapeutic use , Candida albicans/isolation & purification , Candidiasis/drug therapy , Candidiasis/microbiology , Candidiasis/surgery , Empyema, Pleural/drug therapy , Empyema, Pleural/etiology , Empyema, Pleural/surgery , Endocarditis, Bacterial/drug therapy , Endocarditis, Bacterial/surgery , Heart Valve Prosthesis Implantation , Humans , Lung Abscess/drug therapy , Lung Abscess/etiology , Lung Abscess/surgery , Male , Staphylococcal Infections/drug therapy , Staphylococcal Infections/microbiology , Staphylococcal Infections/surgery , Staphylococcus aureus/isolation & purification , Substance Abuse, Intravenous/complications , Thoracoscopy , Tricuspid Valve/microbiology
20.
Article in English | MEDLINE | ID: mdl-30224526

ABSTRACT

Hepatic fungal abscesses are rare in the neonatal period and often constitute a severe complication of the catheterization of the umbilical vessels. Such life-threatening lesions are observed more frequently in preterm than in other newborn infants and the optimal treatment remains uncertain. We present the case of a preterm neonate, who developed an intrahepatic lesion due to parenteral extravasation, successively contaminated by Candida albicans Despite the maximal pharmacological therapies, the treatment that led to the definitive resolution of the abscess was the placement of surgical drainage followed by the direct intralesional administration of liposomal amphotericin B (Ambisome), never described in neonates in the literature, which turned out to be a safe and effective approach.


Subject(s)
Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Candida albicans/drug effects , Candidiasis/drug therapy , Liver Abscess/drug therapy , Candida albicans/growth & development , Candida albicans/pathogenicity , Candidiasis/microbiology , Candidiasis/pathology , Candidiasis/surgery , Catheters, Indwelling , Humans , Infant, Newborn , Infant, Premature , Injections, Intralesional , Intensive Care Units, Neonatal , Liver/drug effects , Liver/microbiology , Liver/pathology , Liver/surgery , Liver Abscess/microbiology , Liver Abscess/pathology , Liver Abscess/surgery , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...